Company intelligence / Profile preview

Kang Cheng Biotechnology

Beijing, Beijing, Chinavlandkc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kang Cheng Biotechnology is a Beijing-based biotech/pharma company established in 2009. It manufactures and exports peptide hormones such as human growth hormone ("HGH Blue Top"), IGF analogs, HCG, HMG, EPO, Melanotan II, CJC1295 without DAC, MGF among others. The company is known for supplying bulk pharmaceutical chemicals globally with a focus on quality assurance and customer-centric service. No clinical trial data or novel drug development pipeline was identified; the business appears focused on commercial-scale production of generic/research-use peptides and related compounds.

Therapeutic areas: Metabolic DisordersEndocrinologyDermatologyHematology
Modalities: PeptidesProtein/peptide hormonesSmall molecule steroids
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Kang Cheng Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kang Cheng Biotechnology.

Explore the full profile